Genoway Valuation
| ALGEN Stock | EUR 3.93 0.09 2.34% |
At this time, the firm appears to be overvalued. Genoway retains a regular Real Value of €3.18 per share. The prevalent price of the firm is €3.93. Our model calculates the value of Genoway from evaluating the firm fundamentals such as Current Valuation of 35.89 M, return on equity of 0.038, and Return On Asset of 0.0019 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Genoway's price fluctuation is slightly risky at this time. Calculation of the real value of Genoway is based on 3 months time horizon. Increasing Genoway's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Genoway's intrinsic value may or may not be the same as its current market price of 3.93, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.93 | Real 3.18 | Hype 3.93 | Naive 3.88 |
The intrinsic value of Genoway's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Genoway's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Genoway helps investors to forecast how Genoway stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genoway more accurately as focusing exclusively on Genoway's fundamentals will not take into account other important factors: Genoway Total Value Analysis
Genoway is presently projected to have takeover price of 35.89 M with market capitalization of 30.77 M, debt of 8.99 M, and cash on hands of 0. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Genoway fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.89 M | 30.77 M | 8.99 M | 0 |
Genoway Investor Information
About 13.0% of the company shares are held by company insiders. The book value of Genoway was presently reported as 1.83. The company had not issued any dividends in recent years. Based on the key measurements obtained from Genoway's financial statements, Genoway is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Genoway Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Genoway connotes not a very effective usage of assets in November.Genoway Ownership Allocation
The market capitalization of Genoway is €30.77 Million. Genoway retains 13.06 (percent) of its outstanding shares held by insiders and 22.4 (percent) owned by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Genoway Profitability Analysis
The company reported the revenue of 14.02 M. Net Loss for the year was (322.6 K) with profit before overhead, payroll, taxes, and interest of 10.2 M.About Genoway Valuation
The stock valuation mechanism determines Genoway's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Genoway based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genoway. We calculate exposure to Genoway's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Genoway's related companies.genOway S.A., a biotechnology company, engages in the development and sale of custom genetically-modified mouse, rat, and cellular models worldwide. The company was founded in 1999 and is based in Lyon, France. GENOWAY operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 105 people.
8 Steps to conduct Genoway's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Genoway's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Genoway's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Genoway's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Genoway's revenue streams: Identify Genoway's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Genoway's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Genoway's growth potential: Evaluate Genoway's management, business model, and growth potential.
- Determine Genoway's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Genoway's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Genoway Stock Analysis
When running Genoway's price analysis, check to measure Genoway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genoway is operating at the current time. Most of Genoway's value examination focuses on studying past and present price action to predict the probability of Genoway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genoway's price. Additionally, you may evaluate how the addition of Genoway to your portfolios can decrease your overall portfolio volatility.